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affecting both men and women. The modern diet and lifestyles, with high meat consumption and
excessive alcohol use, along with limited physical activity has led to an increasing mortality rate for colon
cancer worldwide. As a result, there is a need to develop novel and environmentally benign drug therapies
for colon cancer. Currently, nutraceuticals play an increasingly important role in the treatment of various
chronic diseases such as colon cancer, diabetes and Alzheimer's disease. Nutraceuticals are derived from
various natural sources such as medicinal plants, marine organisms, vegetables and fruits. Nutraceuticals
have shown the potential to reduce the risk of colon cancer and slow its progression. These dietary
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Figure 1 Different classes of nut
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Colon cancer is one of the most dangerous forms of cancer, with
potential to spread to distinct parts of the body including liver, lung,
ovaries and other gastrointestinal organs. So far, 5-ﬂuorouracil (5-FU)
is the ﬁrst choice for colon cancer treatment, acting as an inhibitor of
DNA synthesis1,2. However, while synthetic chemical anticancer
drugs prolong survival, they often have adverse effects and off-
target actions. Based on this, nutraceuticals and phytochemicals have
been investigated for colon cancer therapeutics3. Nutraceutical is a
term derived from nutrition and pharmaceutical, and are sometimes
termed “functional foods”4. Nutritional phytochemicals have a strong
historical background and signiﬁcant applications in modern medicine.
These compounds are used in medicinal and commercial industries for
cosmetics, food aids and additives5.
Nutraceuticals have the ability to control the DNA damaging
factors in cancer cells and regulate DNA transcription in tumors. They
possess numerous therapeutic beneﬁts such as antiobesity effects,
cardiovascular effects, antidiabetic effects, immune enhancement,
natural antioxidant activity, and anti-inﬂammatory effects6,7. Fig. 1
shows different classes of nutraceuticals and their uses. The different
stages of colon cancer warrant various treatment options such as
chemotherapy, surgery, radiation and phytotherapy. All other forms of
cancer therapeutics have signiﬁcant adverse effects. Plant-derived
nutraceuticals are advantageous for the treatment of colon cancer with
additional beneﬁt of improving overall health8. These nutritional
compounds have provided better treatment and showed fewer adverse
effects9. The incidence and mortality rates for colon cancer have been
increasing in most of the countries, particularly US, European and part
of Asian countries. This increasing incidence of colon cancer appearsraceuticals and their uses.due to changing dietary constituents, physical activity patterns, as well
as genetic inﬂuences10. Fig. 2 shows the mortality and incidence rate
of colon cancer in 2005–2012.
Reactive oxygen species can cause problems in normal cells. Free
radicals such as O2
– and OH may increase normal human colonocyte
activity and result in the formation colon polyps. Natural antioxidants
such as quercetin are derived from fruits and plant resources and can
limit the oxidative damage in colon cells. Quercetin belongs to a
family of plant-derived ﬂavonoid phytochemicals and is effective for
inducing apoptosis in colon cancer cells. Likewise, dietary uses of
onion might be able to suppress the proliferation of normal cells.
Onion contains high levels of quercetin, which inhibits the effects of
colon cancer proliferation in both in vitro and in vivo studies11.
Lentinan naturally occurs in the edible mushroom Lentinus edodes.
The lentinan compound is known as β-1,3-glucan. It is one of the
important drugs used as anticancer agents and is used clinically for
colon cancer treatment. Lentinan signiﬁcantly reduces the formation of
colon tumors in an animal model.
Selenium is an important dietary mineral found in broccoli extract,
red wine, dietary ﬁber, pepper, soya, cloves, fenugreek, ginger, apple
and other vegetables. Selenium is associated with up to a 50%
decrease in the risk for colon cancer12,13. Yellow mustard oil is
synthesized by the brassica family of plants and has been examined
for its potential anticancer properties. Mustard contains a complex
mixture of long-chain polysaccharides that may play a protective role
in colon cancer formation14. Essential oils such as eicosapentanoic
acid (EPA), docosahexaenoic acid (DHA) and omega-3 fatty acids are
also used to treat and prevent cancer and cardiac diseases. Particularly,
the consumption of ﬁsh and ﬁsh products reduces the risk of colon
cancer progression15. Recently developed live micro-organisms such
as probiotics are also important dietary supplement for humans.
Probiotics balance the mix of intestinal microbes and have beneﬁcialFigure 2 The mortality and incidence rate of colon cancer in the
years 2002–2012.
Nutraceuticals and plant derivatives for colon cancer treatment 175effects on the human digestive system. Environmental factors and
dietary habits can alter the colonic bacteria and lactobacilli concentra-
tion, and may lead to the formation of polyps and malignant tumors.
Hence intake of probiotics may inhibit preliminary cancer cell
growth16. The clinically used probiotics may be effective in preventing
colon cancer progression in an N-nitroso-N-methylurethene-induced
murine colon adenocarcinoma model in mice. Cancer cells from the
spleen of treated mice were isolated and puriﬁed by ﬂow cytometry
for mRNA analysis. The diseased mice were continuously fed
probiotics to monitor recovery from epithelial or crypt damage17.
However, the therapeutic beneﬁts of nutraceuticals have not yet
been clearly demonstrated. Nonetheless, preliminary characteriza-
tion and epidemiological studies show that different nutritional
packages can control and prevent colon dysfunction. Dietary
supplements enhance colon activity and reduce the incidence of
colon cancer. These nutraceuticals could be naturally occurring in
various plants, bacteria, fungi, algae and marine resources. Hence,
this review focuses on important nutraceutical compounds derived
from the plant and marine sources as used for treating and
controlling colon cancer behavior.Figure 3 Biochemical metabolic response of colon cancer cells.
The proposed mechanism of colorectal tumorigenesis: MDH, malate dehy-
drogenase; PHD, prolyl hydroxylase; HRE, hypoxia-responsive element;
FIH-1, factor inhibiting HIF-1; TAD-C, C-terminal transcriptional activa-
tion domain; UGP2, UDP-glucose pyrophosphorylase 2; GSK3, glycogen
synthetase kinase 3; ECM, extracellular matrix; pVHL, von Hippel–Lindau
protein; TCA, tricarboxylic acid. Red upward pointing arrows and green
downward pointing arrows denote the up-regulation and down-regulation
of enzymes of metabolic pathways, respectively. All altered proteins found
in the present study are highlighted as follows: up-regulated proteins are in
red, and down-regulated proteins are in blue19.2. Colon cancer and bioenergetics pathways
So far, many studies have shown that nutraceutical metabolites can
regulate tumor metabolism and growth. The biochemical observa-
tions on colon cancer are expressed in abnormal levels of common
enzymes and radical changes in the glycolysis pathway. Lactate
dehydrogenase (LDH) is a cluster of enzymes involved in energy
metabolism. LDH is one of the marker enzymes for the detection
of colorectal cancer; it has been shown that increases in the level
are associated with the initial stages of colon cancer18. Fig. 3
shows the biochemical metabolic changes in colon cancer cells.
2.1. Alteration in carbohydrate metabolism
Glycolysis, TCA and HMG-CoA metabolic pathways are often
altered in cancer cell metabolism. The mevalonate and ketogenesis
pathways are increased in tumor cells. Koukourakis et al.20 showed
that HMG-CoA reductase expression is very high in human colon
cancer. The higher activity of HMG-CoA reductase and high levels
of mevalonate-derived metabolites such as isoprenoid compounds are
clear evidence of cancer formation. The study showed that important
biomolecules are differentially regulated between cancer and normal
cells, with signiﬁcant differences in metabolites of colon cancer
tissues. The intermediates of the tricarboxylic acid cycle and lipids
were decreased in cancer cells; however, metabolites in the urea
cycle, purine, pyrimidine and amino acid synthesis were generally at
above normal levels compared to normal colon mucosa21.
2.2. Alterations in fat metabolism
Fatty acid metabolism is a hallmark for ﬁnding various chronic
diseases including cancer. The altered fatty acid metabolism indicates
decreased fat synthesis and increases lipolysis from liver and adipose
tissue storage lipids. In cancer the fatty acid oxidation rate observed
in colon and gastric cancer is very high. The colon cancer sample was
monitored by indirect calorimetry and urinary nitrogen excretion
showed signiﬁcantly higher fat oxidation rates and higher carbohy-
drate oxidation rates22. The de novo fatty acid synthesis pathway of
cancer cells showed abnormal levels of several lipogenic enzymes.
The consequent decrease in lipogenesis is advantageous to a furthercascade of biosynthetic anabolic activities and cell growth23.
In cancer cells, the enzymes ATP-citrate lyase (ACL), acetyl CoA
carboxylase (ACC), and fatty acid synthase (FAS) are habitually over
expressed relative to normal cells. Particularly, the FAS is used as a
cancer biomarker for diagnostic purposes. Fas inhibitors are able to
suppress carcinogenesis in in vivo cancer mouse model. Inhibition
activates apoptosis in colon and breast cancer cell lines without
affecting normal lipogenic tissues24.3. Nutraceuticals effective for colon cancer therapeutics
Nutraceuticals are thought to enhance human health and prevent
chronic diseases. Fiber content in vegetables and fruits may reduce
the risk of colon cancer formation. These food supplements have
been proposed as chemo-preventive agents for colon cancer treat-
ment. Also, plant-derived polysaccharides act as protective role in the
development of colon lesions25.
Pro-oxidants are associated with a high risk of cancer. Free
radicals can induce posttranscriptional modiﬁcation in cancer and
P. Kuppusamy et al.176over express their related proteins. Antioxidant food supplements
are an important component for treating and controlling cancer
development. Fig. 4 shows clinically important secondary meta-
bolites and their analogous structures. Adequate consumption of
dietary nutraceuticals is a reasonable way to maintain health and
avert the formation of colon cancers. The most common reasons
for the consumption of dietary supplements are to control the
symptoms of cancer and to prevent future disease. Dietary supple-
ments such as microalgae, plant derivatives and vegetables are a
rich source of vitamins, minerals, amino acids and other micro-
nutrients. These natural sources have a major role in health
and disease. Moreover, colon cancer is widely reported as being
reduced by the use of various nutraceuticals such as folate,
calcium, tomato-soy diet, ﬁber and vitamins26. Nevertheless, the
recommended dosage of nutraceuticals is very important and
clearly related to beneﬁt the patients. However, it is necessary to
avoid hypervitaminosis, formation of calculi and other obesity-
related problems27.
Recently, nutraceuticals encapsulated by nanoparticles have
been developed in nanomedicine. The hybrid systems made of
anticancer drugs such as cisplatin, apoferritin, methotrexate and 5-
ﬂurouracil have been developed with a drug delivery carrier like
layered double hydroxide, protein (LDH) and platinum nanopar-
ticles. The nutraceutical-containing nanoparticles rapidly interact
with cancer cells and provide promising anticancer chemotherapy
agents with biocompatibility. Some biological agents/nutraceuti-
cals such as antibodies, proteins, polysaccharides aptamers, and
peptides have been able to direct nanoparticle targeting to tumor
cells. Similarly, targeting nutraceuticals to tumors can enhance
their effectiveness: nanoparticles encapsulating curcumin are more
effective than the free curcumin, eventually inhibiting NF-κB
regulated transcription and angiogenesis28.Figure 4 Structures of clinically important second3.1. Carotenoids for colon cancer
Carotenoids are a major class of secondary metabolites with many
biological activities such as free radical scavenging properties,
skin tone improvement and potential for cancer treatment. Gen-
erally carotenoids are classiﬁed into two main subclasses such as
hydrocarbon carotenoids including β-carotene, α-carotene, lyco-
pene and oxycarotenoids which include lutein and zeaxanthin, as
well as other compounds. Carotenoids have many applications in
the clinical and commercial ﬁelds. β-Carotene has been shown to
be efﬁcient in controlling cellular damage from free radicals.
Secondary metabolites can inﬂuence and effectively react with free
radicals in the inner part of the cell membrane. The natural
compounds have been more effective in maintaining membrane
integrity and antimutagenic properties29. The unsaturated nature of
lycopene has potential efﬁciency to provide free radical scaven-
ging activity and inhibit cancer progression. Lycopene is present in
various dietary sources such as tomatoes, grapes and papaya.
Carotenoids are used for the prevention of colon and gastrointest-
inal cancer30. Tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) is a protein that induces apoptosis in cancer cells.
TRAIL has been targeted in microtubule formation in the cell
cycle. Halocynthiaxanthin is a dietary carotenoid and combined
with TRAIL can signiﬁcantly induce apoptosis in DLD-1 colon
cancer cells. The combined drug treatment involves important
anticancer effects such as poly(ADP-ribose) polymerase cleavage,
induction of caspase inhibitors and nuclear condensation. These
mechanisms of halocynthiaxanthin have shown the potential to
regulate programmed cell death in colon cancer cells. Other
phytochemicals such as xanthophyll, astaxanthin, cryoptoxanthin
and zeaxanthin metabolites have been used for the treatment of
colon cancer31.ary metabolite used in colon cancer treatment.
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Luteolin is found in numerous edible plants and vegetables such as
green pepper, celery and perilla. Naturally isolated luteolin
secondary metabolites are clinically proven to be effective colon
cancer agents. In vivo studies showed that luteolin can decrease
tumor incidence and multiplicity in dimethyl benzanthracene-
induced papillomas. Also, many in vitro studies have reported
that luteolin stimulates apoptosis in several cell lines31,32. Demi-
denko et al.33 demonstrated that luteolin induced HT-29 cell cycle
block, preventing cancer cell growth at the G1/S and G2/M phases.
Furthermore, luteolin suppresses the over expression of some
antiapoptotic proteins in affected cells and regulates the expression
and activity of CDC2 (CDK1) kinase and cyclin B1 proteins,
which initiate the G2/M transition phases observed in luteolin-
treated colon cancer cell lines. Use of moderate concentrations of
luteolin signiﬁcantly increased cancer cell apoptosis.
Fisetin is a ﬂavonoid natural substance, occurring in many fruits
and vegetables including cucumbers. We observed fasting-induced
apoptosis of poly(ADP-ribose) cleavage, which is considered a
biomarker of apoptosis. Similarly, caspase-3 was activated in
ﬁsetin-treated colon cancer cells. Fisetin can modulate the expres-
sion of Bcl-2 metabolites to induce the mitochondrial apoptotic
pathway in cancer cells and increases the proapoptotic Bak protein
in colon cancer cells34.3.3. Polyphenolic clusters for colon cancer therapeutics
Polyphenols are natural phytochemicals used to treat various viral
and fungal diseases. They are derived from various sources such as
plants, seaweeds, marine algae and microorganisms. Polyphenols
includes different organic constituents such as ﬂavones, ﬂavanols,
isoﬂavones, catechins, epigallocatechin-3 gallate (EGCG) and
epicatechins. Numerous plants are reported to have polyphenols
in their extracts. Polyphenols isolated from tea plants are well
studied for their biological properties. Consumption of green tea
protects against several types of chemically induced cancer in
animal models35. Green/black tea is one of the most popular and
easily affordable drinks in the world. It has important active
metabolites and antioxidant compounds to enhance the health
beneﬁts. Green tea contains a high amount of antioxidant poly-
phenols which effectively controlled cancerous growth in both
in vitro and in vivo models. Green tea contains many phytochem-
icals such as heterocyclic amines, ﬂavones and saponins, and can
alter the xenobiotic metaboling enzymes. These metabolites induce
the signal transduction pathway which leads to induction of
apoptosis and cell cycle arrest. Some studies have asserted that
the high consumption of black tea is also associated with reducing
the risk of digestive track cancers36.
Curcumin is one of the most important secondary metabolites for
anticarcinogenic properties and is already used clinically. Curcumin
affects the molecular level of protein expression in colon cancers
such as COX-2, VEGF, IL-1, IL-6, IGF and Chemokines. The drug
targets the active site of COX-2 in malignant cells and it modulates
the action of TNF-α and NF-κB factors. Likewise, curcumin is well
known clinically as a chemopreventive agent used during the
initiation and progression stages of digestive tract cancer37. Wang
et al.38 have explained that curcumin inhibits the secretion of
gastrointestinal hormones such as neurotensin. Human colorectal
cancer cell line HCT 116 treated with curcumin altered the hormoneneurotensin action and induced the IL-8 expression in a time- and
dose-dependent manner.4. Marine nutraceuticals and their derivatives for colon
cancer
The marine environment contains an extreme diversity of micro- and
macro-organisms. Marine organisms contain structurally diverse bioac-
tive compounds including many that are included in food and health
care products. Marine organisms produce novel and pharmacological
compounds with fewer adverse effects. Marine-derived bioactive
compounds are of current interest to cure several ailments including
colon cancers. However, researchers are focusing more on secondary
metabolites isolated from marine and other natural sources. Recently
natural product research has reported that from 1981 to 2012, 45% of
new drugs and 80% drugs approved for anticancer agents were derived
from natural products39,40.
4.1. Acetylapoaranotin
Acetylapoaranotin is a diketopiperazine disulﬁde that was isolated
from marine Aspergillus sp. The acetylapoaranotin chemical structure
contains disulﬁde bridges, which are responsible for the molecule's
cytotoxicity. The natural acetylapoaranotin compound can induce
apoptosis in human colon cancer cells (HCT116) as conﬁrmed by
different apoptotic assays such as annexin-V/PI staining and PARP,
caspase-3, -8, -9, and Bax cleavage. This compound also signiﬁcantly
inhibits tumor growth in vivo. Choi and researchers41 are evaluating
the molecular role of diketopiperazine disulﬁdes in apoptosis of the
HCT 116 colon cancer cell line. Acetylapoaranotin has promising
activity to regulate the Bcl-2 family of proteins and the proapoptotic
protein Bax. Treatment of the cancer cell line HCT 116 with different
concentrations of diketopiperazine disulﬁdes was shown to initiate
the caspase 8 activation in intrinsic and extrinsic pathways. Various
types of marine-derived compounds have numerous biomedical
applications such as the neuroprotective properties of seaweeds,
chitosan for weight management and dentistry. Also marine plants
and animals have a rich source of novel compounds with promising
uses in the nutraceutical, medicinal and commercial food industries42.
The marine-based nutraceuticals such as glucon, sulphated polysac-
charides, peptides and fatty acid immunomodulators have great
application in the pharmacological and commercial industries.
Seaweed-derived peptides and proteins can modulate the intestinal
epithelium cell permeability and consequently enhance the intestinal
absorption of macromolecules through the energetic pathways43.
4.2. Astaxanthin
Astaxanthin is one of the carotenoid classes of secondary metabolites,
and is abundantly produced by Haematococcus pluvialis, crab and
marine animals. The highest content of astaxanthin was found in H.
pluvialis, a single-celled green algae. It's chemical name is 3,30-
dihydroxy-β,β-carotene-4,40-dione. Astaxanthin (ASTX) has diverse
biological applications to control colon ulcers, inﬂammation, cancer,
and neurological disorders. Astaxanthin is also used as a food
supplement to enhance the optimal health for humans44. Treatment
of a colon cancer mouse model with astaxanthin was shown to
generate normal expression of NF-κB, MMP9, IL-6, TNFα, COX-2,
and inhibit proliferation and induce apoptosis. Also, dietary ASTX
signiﬁcantly suppressed the formation of colonic mucosal ulcers and
dysplastic crypts in an animal model. NF-κB is a transcription factor
P. Kuppusamy et al.178which participates in a wide range of cellular roles and cancer
pathways. NF-κB factors are critically involved in various signaling
mechanisms, particularly which regulate posttranscriptional function.
Astaxanthin has speciﬁc functional groups to regulate the NF-κB
proteins45. Prabhu et al.46 reported that 1,2-dimethylhydrazine (DMH)-
induced colon carcinogenesis was markedly reduced by astaxanthin. It
has a good chemopreventive effect on lipid peroxidation, antioxidant
status, the total number of aberrant crypt foci (ACF), and cell
proliferation, and eventually reduced the histological lesions in a
rat model.
4.3. Siphonaxanthin
Siphonaxanthin is isolated from the marine green alga Codium fragile
and remarkably suppresses cell viability, and induces apoptosis in
human leukemia and colon cells47. Siphonaxanthin has signiﬁcant anti-
angiogenic activity by suppressing endothelial cell proliferation and
HUVEC tube formation. Although siphonaxanthin had a strong
inhibitory effect on micro-vessel formation in an angiogenic model,
it might not act through signal transduction by VEGF receptor-2.
Ganesan et al.48 reported that siphonaxanthin induces apoptosis in HL-
60 cells through caspase-3 activation, which has been associated with
the enhancement of GADD45α and DR5 expression levels as well as
the suppression of Bcl-2 expression. GADD45α is an important
apoptosis regulator that induces cell cycle arrest and DR5 death
receptor. Table 1 shows the nutraceuticals targeting colon cancer at the
molecular level.5. Dietary supplements for colon cancer prevention
Nutraceutical products and their active metabolites effectively suppress
a wide range of colon cancer cell lines, namely HCT-116, HT-29, SW
480, SW 620, CaCo2 and LoVo. In vitro studies of various antioxidant
fruits including black raspberry, strawberry, and grape seeds were
proven to reduce intestinal tumors64,65. Garlic has a diverse nutritional
proﬁle and is used to treat common and endemic diseases. Garlic con-
tains various dietary ingredients such as organosulfur and S-allylcys-
teine compounds. It is a main precursor for inhibiting the growth of
colon cancer in a clinical model. Rats used for experimental studies byTable 1 Nutraceuticals effectively control the progression of colon
Nutraceuticals Molecular mechanism
α-Tocopheral Antiproliferation, oxidative phospho
Silbinin Reduced cell growth
Fenugreek Cytokines, redox reactions
Curcumin (turmeric) Stimulation of MAPk, Plsk/Akt
Iron foods Transferrin receptor (TfR1)
Graph seed Control the signaling related epigen
Zerumbone Upregulation of DR4 and DR5 MM
Allicin Inhibit the over expression TNF-α f
Rhizochalin Caspase-3 and PRAP activation
Fucoxanthin Induce apoptosis
Protein and peptides (milk) Hypoproliferation of epitheliam
Garcinol Inhibition of tyrosine phosphorylatio
Xanthohumol Upregulation of caspase-3, -8, -9
Boswellic acid Decrease in cyclin D1 expression
β-Escin Induced cell cycle arrest at the G1/S
Quercetin Inhibition of cyclin D1 expression
Fisetin Activation of NF-κB and decrease inoral administration of garlic extract exhibited decreased multiplication
of cancer cells in the initiation stage, but during the late stage the
extract was not effective. Also the extract has no clear scientiﬁc
evidence for cancer preventive efﬁcacy. Garlic extract also has some
toxicity, increasing hemolysis and increasing the anemic condition of
the patient66. Fenugreek has high content of diosgenin, and it belongs
to the steroidal group of saponins. Its cancer-preventative mechanisms
have not been fully studied. So far some activity of the fenugreek crude
extract supported the anti-proliferation activity against leukemia, colon
and breast cancer cell lines67.
5.1. Honey (eugenol)
Eugenol is a natural compound which is derived from honey and is
present in some plant extracts including clove oil, cinnamon, Flos
Magnolia, citrus and balm. Eugenol exhibited novel medical applica-
tions for curing various chronic diseases. It promotes apoptosis in
colon cancer cells68. Eugenol is a potential natural drug against colon
cancer. Eugenol stimulates cell division in sub-G1 phase inducing
apoptosis in regular time-dependent manner. It acts as a transducer of
an apoptosis signal to control the production of non-protein thiols and
matrix metallo-proteins (MMP). Eugenol-treated colon cancer cells
demonstrated increased p53 activation and proline rich acidic protein
(PRAP) cleavage69.
5.2. Omega-3 fatty acids
Fatty acids are long chain hydrocarbons which may vary from 10 to 30
carbons and are a component of lipids. Fatty acids such as saturated
fatty acids and unsaturated fatty acids are found in marine ﬁshes,
microalgae, seaweeds, ﬁsh oil, algae oil and eggs. Omega-3 PUFAs
have been broadly studied in clinical and pathological conditions. The
consumption of omega-3-PUFAs and nutraceutical foods has been
correlated with human health beneﬁts. Omega-3 fatty acids have many
clinical beneﬁts, including reducing the risk of tumor growth and
metastasis. The highest level of omega-3 fatty acids can alter
eicosanoid synthesis and have anti-catabolic effects. The supplementa-
tion of these essential fatty acids, eicosapentaenoic acids (EPA),
docosahexaenoic acid (DHA), protects against colon and breast
cancer70. Hence, it controls weight loss in cancer patients, regulatescancer cell.
Cancer cell line Ref.
rylation HCT-116 49
HT-29 49
HT-29 50
HT29 51
Cao-2, HCT-116 52
etics, oncogene expression HCT-116 53
P-9, Cdc family HCT-116 54
amily gene HCT-116 55
HT-29 56
Caco-2, HT-29 57
HCT-116 58
n HT-29 59
HT-29 60
HT-29 61
phase HT-29 62
SW 480 63
cyclin D1 expression HT-29 34
Table 2 Different dietary nutraceuticals using for anticolon cancer and preventive medicine
Secondary metabolites Sources Cancer cell lines Applications Ref.
Oleuropein Olive tree leaves Colon cancer cell line Protect DNA damage 75
Vitamin D (25-hydroxy vitamin D) Milk and milk based products Colon cancer cell line Reducing the colon cancer development 76
Procyanidins Apple fruit SW 480, SW 620 Differentiation of apoptosis function 77
Scallian Allium ﬁstulosum CT-26 Effect of inhibit colorectal tumor growth 78
Centella asiatica crude extract Whole plant Caco-2 colon cancer Regulate the cell cycle 79
Salograriolide A Centaurea ainetensis HCT-116 Reduce the colon tumor formation 80
Avenanthramides Oats HCT-116 Attenuates of colon cancer cells 81
Brachylaena ramiﬂora crude extract Whole plant HCT-116 Control the p53 tumor gene 82
Crude Lentinus edodes extract Mushroom fruit bodies HCT-116 Regulate the apoptosis of cancer cells 83
Resveratrol Grapes, wines HCT-116 Stimulate p53 gene for apoptosis 84
Conjugated linolinic acid Probiotic bacteria Colorectal cancer Enhance apoptosis of tumor cells 17
Crude phenolics extract Cichorium endlvia. L. HCT-116 Induction of IL-3 expression 35
Garlic crude extract Allium sativum HT-29 Inducing apoptotic cell death 66
Nutraceuticals and plant derivatives for colon cancer treatment 179cytokine production and stabilizes the energy metabolism. Several
clinical studies evaluated high fat and low carbohydrate ﬁsh oil
supplement as a potential therapeutic for colon cancer. Omega-3 fatty
acid contains in ﬁsh oil supplements, stimulates the immune response
and enhances apoptosis in cancer cells71. Fusano et al.72 suggested that
n-3 fatty acids have antitumor effects during the initiation stages of
colon carcinoma. The omega-3 fatty acids reduce the proliferation of
early-stage colonic cancers, which may reduce the progression color-
ectal polyps and may help protect high-risk individuals from colon
cancer.5.3. Vitamins for colon cancer prevention
Vitamins are playing essential role in cancer prevention and
treatment. Folic acid plays a major role in DNA methylation and
DNA synthesis. It conjugates with vitamins B6 and B12 in the single
carbon methyl cycle. Vitamin B complex treatment was initiated to
reduce the risk of colon, rectal and breast cancer73. Similarly, vitamin
D receptor molecules are highly expressed in colon cancer cells, and
may control the abnormal metastasis and regulate the cell death
mechanism in colon cells74. Table 2 illustrates the different dietary
nutraceuticals tested in colon cancer preventive medicine.6. Future prospective
The ﬁnger prints of phytochemical compounds, especially nutraceu-
ticals, are well established for the treatment of colon cancer. Dietary
phytochemicals are widely used as pharmaceuticals beneﬁcial for
human health and other commercial products. However, the mechan-
isms of action of nutritional databases need further development and
better molecular identiﬁcation in colon cancer treatment. Also the
in vivo data for many potent dietary phytochemicals activities is not yet
analyzed. Nevertheless, the scientiﬁc community will be focused on
naturally occurring nutraceuticals and their application in colon cancer
therapeutics in detail. The natural diet contains diverse secondary
metabolites such as ﬂavonoids, steroids, sulphur-containing com-
pounds, alkaloids, saponins, phenolic acids, vitamins, minerals and
other antioxidant enzymes. These nutraceutical compounds may
increase the protection from different factors such as red meat, high
alcohol consumption and other drugs. Research has proven that the
high intake of nutraceuticals is beneﬁcial in the control of colon cancer
generation. Finally, it should be recognized that single or clustereddietary nutraceuticals molecules are contributing to therapeutic action
and will be important for future assessment.Acknowledgment
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